Nox and renal disease

Clinical Science

Volumn 128, Issue 8, 2015, Pages 465-481

  Holterman, Chet E ^a   Read, Naomi C ^b   Kennedy, Christopher R J ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

NADPH oxidase; Reactive oxygen species; Renal disease

Indexed keywords

CALCIUM; LIPID; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; ISOENZYME;

ACUTE KIDNEY FAILURE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DNA DAMAGE; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROLITHIASIS; NEPHRON; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; REVIEW; TRANSCRIPTION INITIATION; ANIMAL; CHEMISTRY; ENZYMOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; HUMANS; ISOENZYMES; KIDNEY DISEASES; NADPH OXIDASE;

EID: 84927171826     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20140361     Document Type: Review

References (161)

1. Wang, D., Chen, Y., Chabrashvili, T., Aslam, S., Borrego Conde, L.J., Umans, J.G. and Wilcox, C.S. (2003) Role of oxidative stress in endothelial dysfunction and enhanced responses to angiotensin II of afferent arterioles from rabbits infused with angiotensin II. J. Am. Soc. Nephrol. 14, 2783-2789
2. Brandes, R.P., Weissmann, N. and Schroder, K. (2014) Nox family NADPH oxidases: Molecular mechanisms of activation. Free Radic. Biol. Med. 76C, 208-226
3. Sedeek, M., Nasrallah, R., Touyz, R.M. and Hebert, R.L. (2013) NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. J. Am. Soc. Nephrol. 24, 1512-1518
4. Gill, P.S. and Wilcox, C.S. (2006) NADPH oxidases in the kidney. Antioxid. Redox Signal. 8, 1597-1607
5. Nistala, R., Whaley-Connell, A. and Sowers, J.R. (2008) Redox control of renal function and hypertension. Antioxid. Redox Signal. 10, 2047-2089
6. Araujo, M. and Wilcox, C.S. (2014) Oxidative stress in hypertension: role of the kidney. Antioxid. Redox Signal. 20, 74-101
7. Whaley-Connell, A. and Sowers, J. (2012) Oxidative stress in the cardiorenal metabolic syndrome. Curr. Hypertens. Rep. 14, 360-365
8. Kashihara, N., Haruna, Y., Kondeti, V.K. and Kanwar, Y.S. (2010) Oxidative stress in diabetic nephropathy. Curr. Med. Chem. 17, 4256-4269
9. Bedard, K., Jaquet, V. and Krause, K.H. (2011) NOX5: from basic biology to signaling and disease. Free Radic. Biol. Med. 52, 725-734
10. Fulton, D.J.R. (2009) Nox5 and the regulation of cellular function. Antioxid. Redox Signal. 11, 2443-2452
11. Kawahara, T. and Lambeth, J.D. (2008) Phosphatidylinositol (4, 5)-bisphosphate modulates Nox5 localization via an N-terminal polybasic region. Mol. Biol. Cell 19, 4020-4031
12. Kawahara, T., Ritsick, D., Cheng, G. and Lambeth, J.D. (2005) Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation. J. Biol. Chem. 280, 31859-31869
13. Pandey, D., Patel, A., Patel, V., Chen, F., Qian, J., Wang, Y., Barman, S.A., Venema, R.C., Stepp, D.W., Rudic, R.D. and Fulton, D.J. (2012) Expression and functional significance of NADPH oxidase 5 (Nox5) and its splice variants in human blood vessels. Am. J. Physiol. Heart Circ. Physiol. 302, H1919-1928
14. Kawahara, T., Jackson, H.M., Smith, S.M., Simpson, P.D. and Lambeth, J.D. (2011) Nox5 forms a functional oligomer mediated by self-association of its dehydrogenase domain. Biochemistry 50, 2013-2025
15. Wang, Y., Chen, F., Le, B., Stepp, D.W. and Fulton, D.J. (2014) Impact of Nox5 polymorphisms on basal and stimulus-dependent ROS generation. PLoS ONE 9, e100102
16. Chabrashvili, T., Tojo, A., Onozato, M.L., Kitiyakara, C., Quinn, M.T., Fujita, T., Welch, W.J. and Wilcox, C.S. (2002) Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39, 269-274
17. Gorin, Y., Block, K., Hernandez, J., Bhandari, B., Wagner, B., Barnes, J.L. and Abboud, H.E. (2005) Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J. Biol. Chem. 280, 39616-39626
18. Jha, J.C., Gray, S.P., Barit, D., Okabe, J., El-Osta, A., Namikoshi, T., Thallas-Bonke, V., Wingler, K., Szyndralewiez, C., Heitz, F. et al. (2014) Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. J. Am. Soc. Nephrol. 25, 1237-1254
19. Pandey, D., Patel, A., Patel, V., Chen, F., Qian, J., Wang, Y., Barman, S.A., Venema, R.C., Stepp, D.W., Daniel Rudic, R. and Fulton, D.J.R. (2012) Expression and functional significance of NADPH oxidase 5 (Nox5) and its splice variants in human blood vessels. Am. J. Physiol. Heart Circ. Physiol. 302, H1919-H1928
20. Wingler, K., Wunsch, S., Kreutz, R., Rothermund, L., Paul, M. and Schmidt, H.H.H.W. (2001) Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic. Bio. Med. 31, 1456-1464
21. Montezano, A.C., Burger, D., Paravicini, T.M., Chignalia, A.Z., Yusuf, H., Almasri, M., He, Y., Callera, G.E., He, G., Krause, K.H. et al. (2010) Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells. Circ. Res. 106, 1363-1373
22. Geiszt, M.s., Kopp, J.B., Várnai, P.T. and Leto, T.l. (2000) Identification of Renox, an NAD(P)H oxidase in kidney. Proc. Natl. Acad. Sci. U.S.A. 97, 8010-8014
23. Yang, Y., Zhang, Y., Cuevas, S., Villar, V.A., Escano, C., Asico, D.L., Yu, P., Grandy, D.K., Felder, R.A., Armando, I. and Jose, P.A. (2012) Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase. Free Radic. Bio. Med. 53, 437-446
24. Han, W., Li, H., Villar, V.A.M., Pascua, A.M., Dajani, M.I., Wang, X., Natarajan, A., Quinn, M.T., Felder, R.A., Jose, P.A. and Yu, P. (2008) Lipid rafts keep NADPH oxidase in the inactive state in human renal proximal tubule cells. Hypertension 51, 481-487
25. Sedeek, M., Callera, G.E., Montezano, A., Gutsol, A., Heitz, F., Szyndralewiez, C., Page, P., Kennedy, C.R., Burns, K.D., Touyz, R.M. and Hebert, R.L. (2010) Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney-implications in type 2 diabetic nephropathy. Am. J. Physiol. Renal. Physiol. 299, F1348-1358
26. Chen, J., Chen, J.-K. and Harris, R.C. (2012) Angiotensin II induces epithelial-to-mesenchymal transition in renal epithelial cells through reactive oxygen species/Src/caveolin-mediated activation of an epidermal growth factor receptor-extracellular signal-regulated kinase signaling pathway. Mol. Cell. Biol. 32, 981-991
27. New, D.D., Block, K., Bhandhari, B., Gorin, Y. and Abboud, H.E. (2011) IGF-I increases the expression of fibronectin by Nox4-dependent Akt phosphorylation in renal tubular epithelial cells. Am. J. Physiol. Cell Physiol. 302, C122-C130
28. Yu, P., Han, W., Villar, V.A.M., Yang, Y., Lu, Q., Lee, H., Li, F., Quinn, M.T., Gildea, J.J., Felder, R.A. and Jose, P.A. (2014) Unique role of NADPH oxidase 5 in oxidative stress in human renal proximal tubule cells. Redox Biol. 2, 570-579
29. Liu, R., Garvin, J.L., Ren, Y., Pagano, P.J. and Carretero, O.A. (2007) Depolarization of the macula densa induces superoxide production via NAD(P)H oxidase. Am. J. Physiol. Renal Physiol. 292, F1867-1872
30. Zhang, R., Harding, P., Garvin, J.L., Juncos, R., Peterson, E., Juncos, L.A. and Liu, R. (2009) Isoforms and functions of NAD(P)H oxidase at the macula densa. Hypertension 53, 556-563
31. Zhang, J., Chandrashekar, K., Lu, Y., Duan, Y., Qu, P., Wei, J., Juncos, L.A. and Liu, R. (2014) Enhanced expression and activity of Nox2 and Nox4 in the macula densa in ANG II-induced hypertensive mice. Am. J. Physiol. Renal Physiol. 306, F344-F350
32. Massey, K.J., Hong, N.J. and Garvin, J.L. (2012) Angiotensin II stimulates superoxide production in the thick ascending limb by activating NOX4. Am. J. Physiol. Cell Physiol. 303, C781-C789
33. Hong, N.J. and Garvin, J.L. (2012) NADPH oxidase 4 mediates flow-induced superoxide production in thick ascending limbs. Am. J. Physiol. Cell Physiol. 303, F1151-F1156
34. Sun, P., Yue, P. and Wang, W.-H. (2012) Angiotensin II stimulates epithelial sodium channels in the cortical collecting duct of the rat kidney. Am. J. Physiol.Renal Physiol. 302, F679-F687
35. phox-containing NADPH oxidase in mediating the effect of K restriction on ROMK channels and renal K excretion. J. Am. Soc. Nephrol. 18, 2037-2045
36. Nlandu Khodo, S., Dizin, E., Sossauer, G., Szanto, I., Martin, P.-Y., Feraille, E., Krause, K.H. and de Seigneux, S. (2012) NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury. J. Am. Soc. Nephrol. 23, 1967-1976
37. Feraille, E., Dizin, E., Roth, I., Derouette, J.-P., Szanto, I., Martin, P.-Y., de Seigneux, S. and Hasler, U. (2014) NADPH oxidase 4 deficiency reduces aquaporin-2 mRNA expression in cultured renal collecting duct principal cells via increased PDE3 and PDE4 activity. PLoS ONE 9, e87239
38. Eid, A.A., Gorin, Y., Fagg, B.M., Maalouf, R., Barnes, J.L., Block, K. and Abboud, H.E. (2009) Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes 58, 1201-1211
39. Gorin, Y., Ricono, J.M., Kim, N.-H., Bhandari, B., Choudhury, G.G. and Abboud, H.E. (2003) Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am. J. Physiol. Renal Physiol. 285, F219-F229
40. Block, K., Eid, A., Griendling, K.K., Lee, D.-Y., Wittrant, Y. and Gorin, Y. (2008) Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression. J. Biol. Chem. 283, 24061-24076
41. Gorin, Y., Block, K., Hernandez, J., Bhandari, B., Wagner, B., Barnes, J.L. and Abboud, H.E. (2005) Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J. Biol. Chem. 280, 39616-39626
42. Pleskova, M., Beck, K.-F., Behrens, M.H., Huwiler, A., Fichtlscherer, B., Wingerter, O., Brandes, R.P., Mülsch, A. and Pfeilschifter, J. (2005) Nitric oxide down-regulates the expression of the catalytic NADPH oxidase subunit Nox1 in rat renal mesangial cells. FASEB J. 20, 139-141
43. Block, K., Gorin, Y. and Abboud, H.E. (2009) Subcellular localization of Nox4 and regulation in diabetes. Proc. Natl. Acad. Sci. U.S.A. 106, 14385-14390
44. Eid, A.A., Lee, D.Y., Roman, L.J., Khazim, K. and Gorin, Y. (2013) Sestrin 2 and AMPK connect hyperglycemia to Nox4-dependent endothelial nitric oxide synthase uncoupling and matrix protein expression. Mol. Cell. Biol. 33, 3439-3460
45. Lee, D.-Y., Wauquier, F., Eid, A.A., Roman, L.J., Ghosh-Choudhury, G., Khazim, K., Block, K. and Gorin, Y. (2013) Nox4 NADPH oxidase mediates peroxynitrite-dependent uncoupling of endothelial nitric-oxide synthase and fibronectin expression in response to angiotensin II: role of mitochondrial reactive oxygen species. J. Biol. Chem. 288, 28668-28686
46. Shah, A., Xia, L., Goldberg, H., Lee, K.W., Quaggin, S.E. and Fantus, I.G. (2013) Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells. J. Biol. Chem. 288, 6835-6848
47. Gao, L., Huang, W. and Li, J. (2013) NOX1 abet mesangial fibrogenesis via iNOS induction in diabetes. Mol. Cell. Biochem. 382, 185-191
48. Holterman, C.E., Thibodeau, J.-F. o., Towaij, C., Gutsol, A., Montezano, A.C., Parks, R.J., Cooper, M.E., Touyz, R.M. and Kennedy, C.R.J. (2014) Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression. J. Am. Soc. Nephrol. 25, 784-797
49. Sharma, K., Ramachandrarao, S., Qiu, G., Usui, H.K., Zhu, Y., Dunn, S.R., Ouedraogo, R., Hough, K., McCue, P., Chan, L. et al. (2008) Adiponectin regulates albuminuria and podocyte function in mice. J. Clin. Invest. 118, 1645-1656
50. Greiber, S., Munzel, T., Kastner, S., Muller, B., Schollmeyer, P. and Pavenstadt, H. (1998) NAD(P)H oxidase activity in cultured human podocytes: effects of adenosine triphosphate. Kidney Int. 53, 654-663
51. Das, R., Xu, S., Quan, X., Nguyen, T.T., Kong, I.D., Chung, C.H., Lee, E.Y., Cha, S.-K. and Park, K.-S. (2014) Upregulation of mitochondrial Nox4 mediates TGF-β-induced apoptosis in cultured mouse podocytes. Am. J. Physiol. Renal Physiol. 306, F155-F167
52. Winn, M.P., Conlon, P.J., Lynn, K.L., Farrington, M.K., Creazzo, T., Hawkins, A.F., Daskalakis, N., Kwan, S.Y., Ebersviller, S., Burchette, J.L. et al. (2005) A Mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308, 1801-1804
53. Kim, E.Y., Anderson, M., Wilson, C., Hagmann, H., Benzing, T. and Dryer, S.E. (2013) NOX2 interacts with podocyte TRPC6 channels and contributes to their activation by diacylglycerol: essential role of podocin in formation of this complex. Am. J. Physiol. Cell Physiol. 305, C960-C971
54. Liu, R., Ren, Y., Garvin, J.L. and Carretero, O.A. (2004) Superoxide enhances tubuloglomerular feedback by constricting the afferent arteriole. Kidney Int. 66, 268-274
55. Cuevas, S., Zhang, Y., Yang, Y., Escano, C., Asico, L., Jones, J.E., Armando, I. and Jose, P.A. Role of renal DJ-1 in the pathogenesis of hypertension associated with increased reactive oxygen species production. Hypertension 59, 446-452
56. Banday, A.A., Lau, Y.S. and Lokhandwala, M.F. (2008) Oxidative stress causes renal dopamine D1 receptor dysfunction and salt-sensitive hypertension in Sprague-Dawley rats. Hypertension 51, 367-375
57. Simao, S., Fraga, S., Jose, P.A. and Soares-da-Silva, P. (2008) Oxidative stress plays a permissive role in alpha2-adrenoceptor-mediated events in immortalized SHR proximal tubular epithelial cells. Mol. Cell. Biochem. 315, 31-39
58. Asico, L., Zhang, X., Jiang, J., Cabrera, D., Escano, C.S., Sibley, D.R., Wang, X., Yang, Y., Mannon, R., Jones, J.E. et al. Lack of renal dopamine D5 receptors promotes hypertension. J. Am. Soc. Nephrol. 22, 82-89
59. Hollon, T.R., Bek, M.J., Lachowicz, J.E., Ariano, M.A., Mezey, E., Ramachandran, R., Wersinger, S.R., Soares-da-Silva, P., Liu, Z.F. et al. (2002) Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J. Neurosci. 22, 10801-10810
60. Yang, Z., Asico, L.D., Yu, P., Wang, Z., Jones, J.E., Bai, R.K., Sibley, D.R., Felder, R.A. and Jose, P.A. (2005) D5 dopamine receptor regulation of phospholipase D. Am. J. Physiol. Heart Circ. Physiol. 288, H55-H61
61. Yang, Z., Asico, L.D., Yu, P., Wang, Z., Jones, J.E., Escano, C.S., Wang, X., Quinn, M.T., Sibley, D.R., Romero, G.G. et al. (2006) D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R96-R104
62. Zhang, M.Z., Yao, B., Fang, X., Wang, S., Smith, J.P. and Harris, R.C. (2009) Intrarenal dopaminergic system regulates renin expression. Hypertension 53, 564-570
63. Zhang, M.Z., Yao, B., McKanna, J.A. and Harris, R.C. (2005) Cross talk between the intrarenal dopaminergic and cyclooxygenase-2 systems. Am. J. Physiol. Renal Physiol. 288, F840-F845
64. Wilcox, C.S. (2003) Redox regulation of the afferent arteriole and tubuloglomerular feedback. Acta Physiol. Scand. 179, 217-223
65. phox in the macula densa regulates single nephron GFR during angiotensin II infusion in rats. Am. J. Physiol. Heart Circ. Physiol. 292, H1685-H1689
66. Chabrashvili, T., Kitiyakara, C., Blau, J., Karber, A., Aslam, S., Welch, W.J. and Wilcox, C.S. (2003) Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R117-R124
67. Reiser, J. and Mundel, P. (2007) Dual effects of RAS blockade on blood pressure and podocyte function. Curr. Hypertens. Rep. 9, 403-408
68. Benter, I.F., Yousif, M.H., Dhaunsi, G.S., Kaur, J., Chappell, M.C. and Diz, D.I. (2008) Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats. Am. J. Nephrol. 28, 25-33
69. Modlinger, P., Chabrashvili, T., Gill, P.S., Mendonca, M., Harrison, D.G., Griendling, K.K., Li, M., Raggio, J., Wellstein, A., Chen, Y. et al. (2006) RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response. Hypertension 47, 238-244
70. Carlstrom, M., Lai, E.Y., Ma, Z., Patzak, A., Brown, R.D. and Persson, A.E. (2009) Role of NOX2 in the regulation of afferent arteriole responsiveness. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R72-R79
71. Lai, E.Y., Solis, G., Luo, Z., Carlstrom, M., Sandberg, K., Holland, S., Wellstein, A., Welch, W.J. and Wilcox, C.S. (2012) p47(phox) is required for afferent arteriolar contractile responses to angiotensin II and perfusion pressure in mice. Hypertension 59, 415-420
72. Bedard, K., Jaquet, V. and Krause, K.H. NOX5: from basic biology to signaling and disease. Free Radic. Biol. Med. 52, 725-734
73. Gorin, Y. and Block, K. (2013) Nox as a target for diabetic complications. Clin. Sci. 125, 361-382
74. Lambeth, J.D. (2007) Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic. Biol. Med. 43, 332-347
75. Susztak, K., Raff, A.C., Schiffer, M. and Bottinger, E.P. (2006) Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55, 225-233
76. Thallas-Bonke, V., Thorpe, S.R., Coughlan, M.T., Fukami, K., Yap, F.Y., Sourris, K.C., Penfold, S.A., Bach, L.A., Cooper, M.E. and Forbes, J.M. (2008) Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes 57, 460-469
77. Altenhofer, S., Radermacher, K.A., Kleikers, P.W., Wingler, K. and Schmidt, H.H. (2014) Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement. Antioxid. Redox Signal., doi:10.1089/ars.2013.5814
78. Cifuentes-Pagano, E., Csanyi, G. and Pagano, P.J. NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS. Cell. Mol. Life Sci. 69, 2315-2325
79. Liu, G.C., Fang, F., Zhou, J., Koulajian, K., Yang, S., Lam, L., Reich, H.N., John, R., Herzenberg, A.M., Giacca, A. et al. (2012) Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse. Diabetologia 55, 2522-2532
80. You, Y.H., Okada, S., Ly, S., Jandeleit-Dahm, K., Barit, D., Namikoshi, T. and Sharma, K. Role of Nox2 in diabetic kidney disease. Am. J. Physiol. Renal Physiol. 304, F840-F848
81. Sedeek, M., Gutsol, A., Montezano, A.C., Burger, D., Nguyen Dinh Cat, A., Kennedy, C.R., Burns, K.D., Cooper, M.E., Jandeleit-Dahm, K.A., Page, P. et al. (2013) Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of type 2 diabetes. Clin. Sci. 124, 191-202
82. Babelova, A., Avaniadi, D., Jung, O., Fork, C., Beckmann, J., Kosowski, J., Weissmann, N., Anilkumar, N., Shah, A.M., Schaefer, L. et al. (2012) Role of Nox4 in murine models of kidney disease. Free Radic. Bio. Med. 53, 842-853
83. Musante, L., Candiano, G., Petretto, A., Bruschi, M., Dimasi, N., Caridi, G., Pavone, B., Del Boccio, P., Galliano, M., Urbani, A. et al. (2007) Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. J. Am. Soc. Nephrol. 18, 799-810
84. Yang, S.M., Hua, K.F., Lin, Y.C., Chen, A., Chang, J.M., Kuoping Chao, L., Ho, C.L. and Ka, S.M. (2013) Citral is renoprotective for focal segmental glomerulosclerosis by inhibiting oxidative stress and apoptosis and activating Nrf2 pathway in mice. PLoS ONE 8, e74871
85. Tsai, P.Y., Ka, S.M., Chao, T.K., Chang, J.M., Lin, S.H., Li, C.Y., Kuo, M.T., Chen, P. and Chen, A. (2011) Antroquinonol reduces oxidative stress by enhancing the Nrf2 signaling pathway and inhibits inflammation and sclerosis in focal segmental glomerulosclerosis mice. Free Radic. Biol. Med. 50, 1503-1516
86. Guo, J., Ananthakrishnan, R., Qu, W., Lu, Y., Reiniger, N., Zeng, S., Ma, W., Rosario, R., Yan, S.F., Ramasamy, R. et al. (2008) RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis. J. Am. Soc. Nephrol. 19, 961-972
87. Hoffmann, S., Podlich, D., Hahnel, B., Kriz, W. and Gretz, N. (2004) Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J. Am. Soc. Nephrol. 15, 1475-1487
88. Dryer, S.E. and Reiser, J. (2010) TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology. Am. J. Physiol. Renal Physiol. 299, F689-F701
89. Moller, C.C., Wei, C., Altintas, M.M., Li, J., Greka, A., Ohse, T., Pippin, J.W., Rastaldi, M.P., Wawersik, S., Schiavi, S. et al. (2007) Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J. Am. Soc. Nephrol. 18, 29-36
90. Wang, G., Anrather, J., Huang, J., Speth, R.C., Pickel, V.M. and Iadecola, C. (2004) NADPH oxidase contributes to angiotensin II signaling in the nucleus tractus solitarius. J. Neurosci. 24, 5516-5524
91. Wang, Z., Wei, X., Zhang, Y., Ma, X., Li, B., Zhang, S., Du, P., Zhang, X. and Yi, F. (2009) NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury. Cell. Physiol. Biochem. 24, 619-626
92. Kim, E.Y., Anderson, M. and Dryer, S.E. (2012) Insulin increases surface expression of TRPC6 channels in podocytes: role of NADPH oxidases and reactive oxygen species. Am. J. Physiol. Renal Physiol. 302, F298-F307
93. Anderson, M., Roshanravan, H., Khine, J. and Dryer, S.E. (2014) Angiotensin II activation of TRPC6 channels in rat podocytes requires generation of reactive oxygen species. J. Cell Physiol. 229, 434-442
94. Tirone, F., Radu, L., Craescu, C.T. and Cox, J.A. (2010) Identification of the binding site for the regulatory calcium-binding domain in the catalytic domain of NOX5. Biochemistry 49, 761-771
95. Jagnandan, D., Church, J.E., Banfi, B., Stuehr, D.J., Marrero, M.B. and Fulton, D.J. (2007) Novel mechanism of activation of NADPH oxidase 5. calcium sensitization via phosphorylation. J. Biol. Chem. 282, 6494-6507
96. Schaldecker, T., Kim, S., Tarabanis, C., Tian, D., Hakroush, S., Castonguay, P., Ahn, W., Wallentin, H., Heid, H., Hopkins, C.R. et al. (2013) Inhibition of the TRPC5 ion channel protects the kidney filter. J. Clin. Invest. 123, 5298-5309
97. Tian, D., Jacobo, S.M., Billing, D., Rozkalne, A., Gage, S.D., Anagnostou, T., Pavenstadt, H., Hsu, H.H., Schlondorff, J., Ramos, A. and Greka, A. (2010) Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels. Sci. Signal. 3, ra77
98. Pick, E. (2014) Role of the Rho GTPase Rac in the activation of the phagocyte NADPH oxidase: outsourcing a key task. Small GTPases. 5, e27952
99. Neale, T.J., Ojha, P.P., Exner, M., Poczewski, H., Ruger, B., Witztum, J.L., Davis, P. and Kerjaschki, D. (1994) Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen. J. Clin. Invest. 94, 1577-1584
100. Neale, T.J., Ullrich, R., Ojha, P., Poczewski, H., Verhoeven, A.J. and Kerjaschki, D. (1993) Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc. Natl. Acad. Sci. U.S.A. 90, 3645-3649
101. Kinoshita, Y., Kondo, S., Urushihara, M., Suga, K., Matsuura, S., Takamatsu, M., Shimizu, M., Nishiyama, A., Kawachi, H. and Kagami, S. (2011) Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis. Transl. Res. 158, 235-248
102. Peng, H., Takano, T., Papillon, J., Bijian, K., Khadir, A. and Cybulsky, A.V. (2002) Complement activates the c-Jun N-terminal kinase/stress-activated protein kinase in glomerular epithelial cells. J. Immunol. 169, 2594-2601
103. Cybulsky, A.V., Quigg, R.J. and Salant, D.J. (2005) Experimental membranous nephropathy redux. Am. J. Physiol. Renal Physiol. 289, F660-F671
104. Cybulsky, A.V. (2011) Membranous nephropathy. Contrib. Nephrol. 169, 107-125
105. Ren, G., Huynh, C., Bijian, K. and Cybulsky, A.V. (2008) Role of apoptosis signal-regulating kinase 1 in complement-mediated glomerular epithelial cell injury. Mol. Immunol. 45, 2236-2246
106. Kosmadakis, G., Filiopoulos, V., Georgoulias, C., Tentolouris, N. and Michail, S. (2010) Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome. Scand. J. Urol. Nephrol. 44, 251-256
107. Chen, Z.H., Qin, W.S., Zeng, C.H., Zheng, C.X., Hong, Y.M., Lu, Y.Z., Li, L.S. and Liu, Z.H. (2010) Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro. Kidney Int. 77, 974-988
108. LaSpina, M., Tripathi, S., Gatto, L.A., Bruch, D., Maier, K.G. and Kittur, D.S. (2008) An interleukin-6-neutralizing antibody prevents cyclosporine-induced nephrotoxicity in mice. J. Surg. Res. 148, 121-125
109. Vetter, M., Chen, Z.J., Chang, G.D., Che, D., Liu, S. and Chang, C.H. (2003) Cyclosporin A disrupts bradykinin signaling through superoxide. Hypertension 41, 1136-1142
110. phox, Rac-1) and tacrolimus-induced nephrotoxicity in a rat renal transplant model. Nephrol. Dial. Transplant. 22, 376-385
111. Djamali, A., Vidyasagar, A., Adulla, M., Hullett, D. and Reese, S. (2009) Nox-2 is a modulator of fibrogenesis in kidney allografts. Am. J. Transplant. 9, 74-82
112. Djamali, A., Reese, S., Hafez, O., Vidyasagar, A., Jacobson, L., Swain, W., Kolehmainen, C., Huang, L., Wilson, N.A. and Torrealba, J.R. (2012) Nox2 is a mediator of chronic CsA nephrotoxicity. Am. J. Transplant. 12, 1997-2007
113. Rhyu, D.Y., Park, J., Sharma, B.R. and Ha, H. (2012) Role of reactive oxygen species in transforming growth factor-beta1-induced extracellular matrix accumulation in renal tubular epithelial cells. Transplant. Proc. 44, 625-628
114. Vural, A., Yilmaz, M.I., Caglar, K., Aydin, A., Sonmez, A., Eyileten, T., Acikel, C., Gulec, B., Kozak, O. and Oner, K. (2005) Assessment of oxidative stress in the early posttransplant period: comparison of cyclosporine A and tacrolimus-based regimens. Am. J. Nephrol. 25, 250-255
115. Sun, K., Kiss, E., Bedke, J., Stojanovic, T., Li, Y., Gwinner, W. and Grone, H.J. (2004) Role of xanthine oxidoreductase in experimental acute renal-allograft rejection. Transplantation 77, 1683-1692
116. Bhandary, U.V., Shirodkar, B., Tse, W., Hodgkinson, A.D. and Demaine, A.G. (2011) A polymorphism of NADPH oxidase p22phox is associated with reduced susceptibility to acute rejection in renal allograft recipients. Transpl. Immunol. 25, 16-19
117. Gelderman, K.A., Hultqvist, M., Pizzolla, A., Zhao, M., Nandakumar, K.S., Mattsson, R. and Holmdahl, R. (2007) Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J. Clin. Invest. 117, 3020-3028
118. Gardiner, G.J., Deffit, S.N., McLetchie, S., Perez, L., Walline, C.C. and Blum, J.S. (2013) A role for NADPH oxidase in antigen presentation. Front. Immunol. 4, 295
119. Kraaij, M.D., Savage, N.D., van der Kooij, S.W., Koekkoek, K., Wang, J., van den Berg, J.M., Ottenhoff, T.H., Kuijpers, T.W., Holmdahl, R., van Kooten, C. and Gelderman, K.A. (2010) Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 107, 17686-17691
120. Kraaij, M.D., van der Kooij, S.W., Reinders, M.E., Koekkoek, K., Rabelink, T.J., van Kooten, C. and Gelderman, K.A. (2011) Dexamethasone increases ROS production and T cell suppressive capacity by anti-inflammatory macrophages. Mol. Immunol. 49, 549-557
121. Kraaij, M.D., Koekkoek, K.M., Gelderman, K.A. and van Kooten, C. (2014) The NOX2-mediated ROS producing capacity of recipient cells is associated with reduced T cell infiltrate in an experimental model of chronic renal allograft inflammation. Transpl. Immunol. 30, 65-70
122. Basile, D.P., Leonard, E.C., Beal, A.G., Schleuter, D. and Friedrich, J. (2012) Persistent oxidative stress following renal ischemia-reperfusion injury increases ANG II hemodynamic and fibrotic activity. Am. J. Physiol. Renal Physiol. 302, F1494-F1502
123. Reel, B., Guzeloglu, M., Bagriyanik, A., Atmaca, S., Aykut, K., Albayrak, G. and Hazan, E. (2013) The effects of PPAR-gamma agonist pioglitazone on renal ischemia/reperfusion injury in rats. J. Surg. Res. 182, 176-184
124. Gutierrez, E., Egido, J., Rubio-Navarro, A., Buendia, I., Blanco Colio, L.M., Toldos, O., Manzarbeitia, F., de Lorenzo, A., Sanchez, R., Ortiz, A. et al. (2012) Oxidative stress, macrophage infiltration and CD163 expression are determinants of long-term renal outcome in macrohematuria-induced acute kidney injury of IgA nephropathy. Nephron. Clin. Pract. 121, c42-c53
125. Park, C.H., Tanaka, T., Cho, E.J., Park, J.C., Shibahara, N. and Yokozawa, T. (2012) Glycerol-induced renal damage improved by 7-O-galloyl-D-sedoheptulose treatment through attenuating oxidative stress. Biol. Pharm. Bull. 35, 34-41
126. Duan, S.B., Yang, S.K., Zhou, Q.Y., Pan, P., Zhang, H., Liu, F. and Xu, X.Q. (2013) Mitochondria-targeted peptides prevent on contrast-induced acute kidney injury in the rats with hypercholesterolemia. Ren. Fail. 35, 1124-1129
127. Perianayagam, M.C., Liangos, O., Kolyada, A.Y., Wald, R., MacKinnon, R.W., Li, L., Rao, M., Balakrishnan, V.S., Bonventre, J.V., Pereira, B.J. and Jaber, B.L. (2007) NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J. Am. Soc. Nephrol. 18, 255-263
128. Diebold, I., Petry, A., Sabrane, K., Djordjevic, T., Hess, J. and Gorlach, A. (2012) The HIF1 target gene NOX2 promotes angiogenesis through urotensin-II. J. Cell Sci. 125, 956-964
129. Diebold, I., Petry, A., Hess, J. and Gorlach, A. (2010) The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol. Biol. Cell 21, 2087-2096
130. Basile, D.P., Donohoe, D., Roethe, K. and Osborn, J.L. (2001) Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am. J. Physiol. Renal Physiol. 281, F887-F899
131. Basile, D.P., Fredrich, K., Alausa, M., Vio, C.P., Liang, M., Rieder, M.R., Greene, A.S. and Cowley, Jr., A. W. (2005) Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure. Am. J. Physiol. Renal Physiol. 288, F953-F963
132. Pagtalunan, M.E., Olson, J.L., Tilney, N.L. and Meyer, T.W. (1999) Late consequences of acute ischemic injury to a solitary kidney. J. Am. Soc. Nephrol. 10, 366-373
133. Basile, D.P., Donohoe, D.L., Roethe, K. and Mattson, D.L. (2003) Chronic renal hypoxia after acute ischemic injury: effects of L-arginine on hypoxia and secondary damage. Am. J. Physiol. Renal Physiol. 284, F338-F348
134. Humes, H.D., Lake, E.W. and Liu, S. (1995) Renal tubule cell repair following acute renal injury. Miner. Electrolyte Metab. 21, 353-365
135. Scheid, C., Koul, H., Hill, W.A., Luber-Narod, J., Kennington, L., Honeyman, T., Jonassen, J. and Menon, M. (1996) Oxalate toxicity in LLC-PK1 cells: role of free radicals. Kidney Int. 49, 413-419
136. Thamilselvan, S., Byer, K.J., Hackett, R.L. and Khan, S.R. (2000) Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J. Urol. 164, 224-229
137. Khan, A., Byer, K. and Khan, S.R. (2014) Exposure of Madin-Darby canine kidney (MDCK) cells to oxalate and calcium oxalate crystals activates nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase. Urology 83 510, e511-e517
138. Umekawa, T., Iguchi, M., Uemura, H. and Khan, S.R. (2006) Oxalate ions and calcium oxalate crystal-induced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal fibroblasts. BJU Int. 98, 656-660
139. Li, C.Y., Deng, Y.L. and Sun, B.H. (2009) Effects of apocynin and losartan treatment on renal oxidative stress in a rat model of calcium oxalate nephrolithiasis. Int. Urol. Nephrol. 41, 823-833
140. Yoshioka, I., Tsujihata, M., Akanae, W., Nonomura, N. and Okuyama, A. (2011) Angiotensin type-1 receptor blocker candesartan inhibits calcium oxalate crystal deposition in ethylene glycol-treated rat kidneys. Urology 77, e1009-e1007
141. Zuo, J., Khan, A., Glenton, P.A. and Khan, S.R. (2011) Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats. Nephrol. Dial. Transplant. 26, 1785-1796
142. Thamilselvan, V., Menon, M. and Thamilselvan, S. (2012) Selective Rac1 inhibition protects renal tubular epithelial cells from oxalate-induced NADPH oxidase-mediated oxidative cell injury. Urol. Res. 40, 415-423
143. Tsujihata, M., Momohara, C., Yoshioka, I., Tsujimura, A., Nonomura, N. and Okuyama, A. (2008) Atorvastatin inhibits renal crystal retention in a rat stone forming model. J. Urol. 180, 2212-2217
144. Tsujihata, M., Yoshioka, I., Tsujimura, A., Nonomura, N. and Okuyama, A. (2011) Why does atorvastatin inhibit renal crystal retention? Urol. Res. 39, 379-383
145. Joshi, S., Saylor, B.T., Wang, W., Peck, A.B. and Khan, S.R. (2012) Apocynin-treatment reverses hyperoxaluria induced changes in NADPH oxidase system expression in rat kidneys: a transcriptional study. PLoS ONE 7, e47738
146. Demaurex, N., Downey, G.P., Waddell, T.K. and Grinstein, S. (1996) Intracellular pH regulation during spreading of human neutrophils. J. Cell Biol. 133, 1391-1402
147. Tiselius, H.G. (1981) The effect of pH on the urinary inhibition of calcium oxalate crystal growth. Br. J. Urol. 53, 470-474
148. Diebold, I., Petry, A., Hess, J. and Gorlach, A. The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol. Biol. Cell 21, 2087-2096
149. Goyal, P., Weissmann, N., Grimminger, F., Hegel, C., Bader, L., Rose, F., Fink, L., Ghofrani, H.A., Schermuly, R.T., Schmidt, H.H. et al. (2004) Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species. Free Radic. Biol. Med. 36, 1279-1288
150. Vallet, P., Charnay, Y., Steger, K., Ogier-Denis, E., Kovari, E., Herrmann, F., Michel, J.P. and Szanto, I. (2005) Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia. Neuroscience 132, 233-238
151. Block, K., Gorin, Y., Hoover, P., Williams, P., Chelmicki, T., Clark, R.A., Yoneda, T. and Abboud, H.E. (2007) NAD(P)H oxidases regulate HIF-2alpha protein expression. J. Biol. Chem. 282, 8019-8026
152. Maranchie, J.K. and Zhan, Y. (2005) Nox4 is critical for hypoxia-inducible factor 2-alpha transcriptional activity in von Hippel-Lindau-deficient renal cell carcinoma. Cancer Res. 65, 9190-9193
153. Chang, G., Chen, L., Lin, H.M., Lin, Y. and Maranchie, J.K. (2012) Nox4 inhibition enhances the cytotoxicity of cisplatin in human renal cancer cells. J. Exp. Ther. Oncol. 10, 9-18
154. Gregg, J.L., Turner, 2nd, R. M., Chang, G., Joshi, D., Zhan, Y., Chen, L. and Maranchie, J.K. (2014) NADPH oxidase NOX4 supports renal tumorigenesis by promoting the expression and nuclear accumulation of HIF2alpha. Cancer Res. 74, 3501-3511
155. Block, K., Gorin, Y., New, D.D., Eid, A., Chelmicki, T., Reed, A., Choudhury, G.G., Parekh, D.J. and Abboud, H.E. (2010) The NADPH oxidase subunit p22phox inhibits the function of the tumor suppressor protein tuberin. Am. J. Pathol. 176, 2447-2455
156. Nayak, B.K., Feliers, D., Sudarshan, S., Friedrichs, W.E., Day, R.T., New, D.D., Fitzgerald, J.P., Eid, A., Denapoli, T., Parekh, D.J. et al. (2013) Stabilization of HIF-2alpha through redox regulation of mTORC2 activation and initiation of mRNA translation. Oncogene 32, 3147-3155
157. Uniacke, J., Holterman, C.E., Lachance, G., Franovic, A., Jacob, M.D., Fabian, M.R., Payette, J., Holcik, M., Pause, A. and Lee, S. (2012) An oxygen-regulated switch in the protein synthesis machinery. Nature 486, 126-129
158. Mekhail, K., Gunaratnam, L., Bonicalzi, M.E. and Lee, S. (2004) HIF activation by pH-dependent nucleolar sequestration of VHL. Nat. Cell Biol. 6, 642-647
159. Suh, Y.A., Arnold, R.S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A.B., Griendling, K.K. and Lambeth, J.D. (1999) Cell transformation by the superoxide-generating oxidase Mox1. Nature 401, 79-82
160. Chang, G., Chen, L., Lin, H.M., Lin, Y. and Maranchie, J.K. (2012) Nox4 inhibition enhances the cytotoxicity of cisplatin in human renal cancer cells. J. Exp. Ther. Oncol. 10, 9-18
161. Nayak, B.K., Feliers, D., Sudarshan, S., Friedrichs, W.E., Day, R.T., New, D.D., Fitzgerald, J.P., Eid, A., Denapoli, T., Parekh, D.J. et al. (2013) Stabilization of HIF-2alpha through redox regulation of mTORC2 activation and initiation of mRNA translation. Oncogene 32, 3147-3155